Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Feng

Showing results (371-380 of 397) with videos related to

Pageof 40
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2014
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2H S Rugo, K I Pritchard, M Gnant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2022
Corrigendum to "Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis": [Annals of Oncology 33 (2022) 321-329]G Curigliano, V Mueller, V Borges, et al.
Zhonghua Yi Xue Za Zhi|January 17, 2017
[Risk factors for acute rejection in living-donor kidney transplant recipients in China: a subgroup analysis of a multi-center, registry study]X P Hu, Y Tian, T Y Zhu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2014
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†M Piccart, G N Hortobagyi, M Campone, et al.
Cell Reports|December 12, 2019
CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted TherapiesWilliam W Feng, Owen Wilkins, Scott Bang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 21, 2024
[Exploration and validation of optimal cut-off values for tPSA and fPSA/tPSA screening of prostate cancer at different ages]X M Liu, H Y Duan, D Q Zhang, et al.
Geophysical Research Letters|August 30, 2016
Growth in stratospheric chlorine from short-lived chemicals not controlled by the Montreal ProtocolR Hossaini, M P Chipperfield, A Saiz-Lopez, et al.
Physical Review Letters|October 2, 2019
Orbital-Selective Kondo Entanglement and Antiferromagnetic Order in USb_{2}Q Y Chen, X B Luo, D H Xie, et al.
The Review of Scientific Instruments|September 3, 2016
Upgrade of Langmuir probe diagnostic in ITER-like tungsten mono-block divertor on experimental advanced superconducting tokamakJ C Xu, L Wang, G S Xu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 22, 2019
[Practice of parenting and related factors on children aged 0-5 in the urban areas of China]J L X Yang, Y Zhang, W W Feng, et al.
Pageof 40

Showing results (371-380 of 397) with videos related to

Sort By:
Pageof 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2014
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2H S Rugo, K I Pritchard, M Gnant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2022
Corrigendum to "Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis": [Annals of Oncology 33 (2022) 321-329]G Curigliano, V Mueller, V Borges, et al.
Zhonghua Yi Xue Za Zhi|January 17, 2017
[Risk factors for acute rejection in living-donor kidney transplant recipients in China: a subgroup analysis of a multi-center, registry study]X P Hu, Y Tian, T Y Zhu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2014
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†M Piccart, G N Hortobagyi, M Campone, et al.
Cell Reports|December 12, 2019
CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted TherapiesWilliam W Feng, Owen Wilkins, Scott Bang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 21, 2024
[Exploration and validation of optimal cut-off values for tPSA and fPSA/tPSA screening of prostate cancer at different ages]X M Liu, H Y Duan, D Q Zhang, et al.
Geophysical Research Letters|August 30, 2016
Growth in stratospheric chlorine from short-lived chemicals not controlled by the Montreal ProtocolR Hossaini, M P Chipperfield, A Saiz-Lopez, et al.
Physical Review Letters|October 2, 2019
Orbital-Selective Kondo Entanglement and Antiferromagnetic Order in USb_{2}Q Y Chen, X B Luo, D H Xie, et al.
The Review of Scientific Instruments|September 3, 2016
Upgrade of Langmuir probe diagnostic in ITER-like tungsten mono-block divertor on experimental advanced superconducting tokamakJ C Xu, L Wang, G S Xu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 22, 2019
[Practice of parenting and related factors on children aged 0-5 in the urban areas of China]J L X Yang, Y Zhang, W W Feng, et al.
Pageof 40